(Q34466343)

2 August 2017

1 reference

title

Review article: glycyrrhizin as a potential treatment for chronic hepatitis C. (English)

1 reference

2 August 2017

1 reference

1 reference

van Rossum TG

1

1 reference

2 August 2017

Vulto AG

2

1 reference

2 August 2017

de Man RA

3

1 reference

2 August 2017

Brouwer JT

4

1 reference

2 August 2017

Schalm SW

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

Alimentary Pharmacology & Therapeutics

2 August 2017

1 reference

2 August 2017

12

1 reference

2 August 2017

199-205

1 reference

2 August 2017

3

1 reference

The treatment of chronic viral hepatitis

2 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00309.X

The determination of glycyrrhizin in selected UK liquorice products

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00309.X

Clinical investigation of 11 beta-hydroxysteroid dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00309.X

Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11 beta-hydroxysteroid dehydrogenase activity in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00309.X

Glycyrrhizin induces mineralocorticoid activity through alterations in cortisol metabolism in the human kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00309.X

Renin-dependency of glycyrrhizin-induced pseudoaldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00309.X

Glycyrrhizic acid inhibits virus growth and inactivates virus particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00309.X

Inhibition of hepatitis A virus replication in vitro by antiviral compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00309.X

Studies on mechanism of action of glycyrrhizin against hepatitis A virus replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00309.X

Effect of glycyrrhizin on lysis of hepatocyte membranes induced by anti-liver cell membrane antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00309.X

The protective effect of glycyrrhizin against injury of the liver caused by ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00309.X

The long term efficacy of glycyrrhizin in chronic hepatitis C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00309.X

Prolonged therapy of chronic hepatitis C with ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00309.X

10.1046/J.1365-2036.1998.00309.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference